Ortonne JP - Search Results

1

Oral alitretinoin (9-cis-retinoic acid) therapy for chronic hand dermatitis in patients refractory to standard therapy: results of a randomized, double-blind, placebo-controlled, multicenter trial.

Ruzicka T, Larsen FG, Galewicz D, Horváth A, Coenraads PJ, Thestrup-Pedersen K, Ortonne JP, Zouboulis CC, Harsch M, Brown TC, Zultak M. Ruzicka T, et al. Among authors: ortonne jp. Arch Dermatol. 2004 Dec;140(12):1453-9. doi: 10.1001/archderm.140.12.1453. Arch Dermatol. 2004. PMID: 15611422 Clinical Trial.

2

An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis.

Lebwohl M, Christophers E, Langley R, Ortonne JP, Roberts J, Griffiths CE; Alefacept Clinical Study Group. Lebwohl M, et al. Among authors: ortonne jp. Arch Dermatol. 2003 Jun;139(6):719-27. doi: 10.1001/archderm.139.6.719. Arch Dermatol. 2003. PMID: 12810502 Clinical Trial.

3

Treatment of oral erosive lichen planus with 1% pimecrolimus cream: a double-blind, randomized, prospective trial with measurement of pimecrolimus levels in the blood.

Passeron T, Lacour JP, Fontas E, Ortonne JP. Passeron T, et al. Among authors: ortonne jp. Arch Dermatol. 2007 Apr;143(4):472-6. doi: 10.1001/archderm.143.4.472. Arch Dermatol. 2007. PMID: 17438179 Clinical Trial.

4

Tazarotene cream for the treatment of facial photodamage: a multicenter, investigator-masked, randomized, vehicle-controlled, parallel comparison of 0.01%, 0.025%, 0.05%, and 0.1% tazarotene creams with 0.05% tretinoin emollient cream applied once daily for 24 weeks.

Kang S, Leyden JJ, Lowe NJ, Ortonne JP, Phillips TJ, Weinstein GD, Bhawan J, Lew-Kaya DA, Matsumoto RM, Sefton J, Walker PS, Gibson JR. Kang S, et al. Among authors: ortonne jp. Arch Dermatol. 2001 Dec;137(12):1597-604. doi: 10.1001/archderm.137.12.1597. Arch Dermatol. 2001. PMID: 11735710 Clinical Trial.

5

Treatment of chronic erosive oral lichen planus with low concentrations of topical tacrolimus: an open prospective study.

Olivier V, Lacour JP, Mousnier A, Garraffo R, Monteil RA, Ortonne JP. Olivier V, et al. Among authors: ortonne jp. Arch Dermatol. 2002 Oct;138(10):1335-8. doi: 10.1001/archderm.138.10.1335. Arch Dermatol. 2002. PMID: 12374539 Clinical Trial.

6

Superiority of ivermectin 1% cream over metronidazole 0·75% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial.

Taieb A, Ortonne JP, Ruzicka T, Roszkiewicz J, Berth-Jones J, Peirone MH, Jacovella J; Ivermectin Phase III study group. Taieb A, et al. Among authors: ortonne jp. Br J Dermatol. 2015 Apr;172(4):1103-10. doi: 10.1111/bjd.13408. Epub 2015 Feb 11. Br J Dermatol. 2015. PMID: 25228137 Clinical Trial.

7

A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris.

Douglas WS, Poulin Y, Decroix J, Ortonne JP, Mrowietz U, Gulliver W, Krogstad AL, Larsen FG, Iglesias L, Buckley C, Bibby AJ. Douglas WS, et al. Among authors: ortonne jp. Acta Derm Venereol. 2002;82(2):131-5. doi: 10.1080/00015550252948194. Acta Derm Venereol. 2002. PMID: 12125943 Free article. Clinical Trial.

8

A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids.

Murrell DF, Calvieri S, Ortonne JP, Ho VC, Weise-Riccardi S, Barbier N, Paul CF. Murrell DF, et al. Among authors: ortonne jp. Br J Dermatol. 2007 Nov;157(5):954-9. doi: 10.1111/j.1365-2133.2007.08192.x. Br J Dermatol. 2007. PMID: 17935515 Clinical Trial.

9

Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study.

Ortonne JP, Korting HC, Viguié-Vallanet C, Larnier C, Savaluny E. Ortonne JP, et al. J Eur Acad Dermatol Venereol. 2006 Nov;20(10):1307-13. doi: 10.1111/j.1468-3083.2006.01807.x. J Eur Acad Dermatol Venereol. 2006. PMID: 17062050 Clinical Trial.

10

Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo.

Passeron T, Ostovari N, Zakaria W, Fontas E, Larrouy JC, Lacour JP, Ortonne JP. Passeron T, et al. Among authors: ortonne jp. Arch Dermatol. 2004 Sep;140(9):1065-9. doi: 10.1001/archderm.140.9.1065. Arch Dermatol. 2004. PMID: 15381545 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

741 results

Search Page